These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1786895)

  • 1. [Neutrophil function in hematologic disorders].
    Matzner Y
    Harefuah; 1991 Dec; 121(11):449-52. PubMed ID: 1786895
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulocyte dysfunction in hematological disorders.
    Matzner Y
    Cancer Invest; 1992; 10(2):155-61. PubMed ID: 1551025
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia.
    Stenke L; Näsman-Glaser B; Edenius C; Samuelsson J; Palmblad J; Lindgren JA
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():883-6. PubMed ID: 1825431
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro thymidine uptake by circulating leukocytes.
    Sokal JE; Pauly JL
    J Lab Clin Med; 1974 Nov; 84(5):681-91. PubMed ID: 4283790
    [No Abstract]   [Full Text] [Related]  

  • 5. The neutrophil granulocyte in chronic myeloid leukemia.
    Carulli G
    Haematologia (Budap); 1993; 25(1):35-55. PubMed ID: 8339997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
    Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
    Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular deformability studies in leukemia.
    Sharma K
    Physiol Chem Phys Med NMR; 1993; 25(4):293-7. PubMed ID: 8153154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet function in acute leukemias.
    Naresh KN; Sivasankaran P; Veliath AJ
    J Assoc Physicians India; 1993 Jun; 41(6):377-8. PubMed ID: 8005978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myelocytosis in adults. Diagnostic orientation].
    Bernard P
    Rev Prat; 1995 Jun; 45(11):1413-6. PubMed ID: 7659993
    [No Abstract]   [Full Text] [Related]  

  • 10. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
    Hyun BH; Gulati GL; Ashton JK
    Clin Lab Med; 1990 Dec; 10(4):825-38. PubMed ID: 2272176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferons in the treatment of hematological diseases].
    Jantunen E; Nousiainen T
    Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of selected cytochemical studies of mature granulocytes in myelodysplastic syndromes and various other hematologic diseases].
    Mariańska B; Apel D; Maj S
    Acta Haematol Pol; 1991; 22(1):54-7. PubMed ID: 1823968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disorders.
    Cortes J; Kantarjian H
    Cancer; 2004 May; 100(10):2064-78. PubMed ID: 15139047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematological aspects of acro-syndromes].
    Schmidt PM
    Rev Med Suisse Romande; 1992 May; 112(5):413-6. PubMed ID: 1604102
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML.
    Lazarevic V; Golovleva I; Nygren I; Wahlin A
    Am J Hematol; 2006 Jun; 81(6):470-1. PubMed ID: 16680752
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular biologic study in chronic myelogenous leukemia and its related disorders].
    Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1988 Jul; 29(7):1010-7. PubMed ID: 3184468
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Granulocyte dysfunction in hematological diseases].
    Matzner Y
    Gematol Transfuziol; 1993 May; 38(5):41-4. PubMed ID: 8034174
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
    Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
    Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.